Lista de obras - Mohsen Khademi - Dominio Público Uruguay

A Role for VAV1 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

artículo científico publicado en 2009

A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.

artículo científico publicado en 2014

Absence of systemic oxidative stress and increased CSF prostaglandin F2α in progressive MS.

artículo científico publicado en 2016

Affinity proteomic profiling of plasma, cerebrospinal fluid, and brain tissue within multiple sclerosis.

artículo científico publicado en 2014

Age-dependent effects on the treatment response of natalizumab in MS patients

artículo científico publicado en 2014

Altered expression of T cell immunoglobulin-mucin (TIM) molecules in bronchoalveolar lavage CD4+ T cells in sarcoidosis

artículo científico publicado en 2009

Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): suppression of IFN-gamma and TNF-alpha and enhancement of IL-10

scientific article published on 01 September 1999

Analysis of JC virus DNA in NPSLE patients treated with different immunomodulatory agents

artículo científico publicado en 2012

Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.

scientific article published on 19 September 2008

Anoctamin 2 identified as an autoimmune target in multiple sclerosis

artículo científico publicado en 2016

Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis

artículo científico publicado en 2011

Antibody Affinity Against 2009 A/H1N1 Influenza and Pandemrix Vaccine Nucleoproteins Differs Between Childhood Narcolepsy Patients and Controls

artículo científico publicado en 2017

Antibody-based profiling of cerebrospinal fluid within multiple sclerosis

artículo científico publicado en 2013

Antibody-mediated suppression of Vbeta5.2/5.3(+) T cells in multiple sclerosis: results from an MRI-monitored phase II clinical trial

artículo científico publicado en 2002

Autoantibody profiling in multiple sclerosis using arrays of human protein fragments

artículo científico publicado en 2013

Autoantibody targets in vaccine-associated narcolepsy

artículo científico publicado en 2016

CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis

artículo científico publicado en 2012

Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.

artículo científico publicado en 2010

Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis

artículo científico publicado en 2016

Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis.

artículo científico publicado en 2016

Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms

artículo científico publicado en 2015

Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus

article published in 2011

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes

artículo científico publicado en 2015

Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis

artículo científico publicado en 2016

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

artículo científico publicado en 2009

Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function

artículo científico publicado en 2016

Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis.

artículo científico publicado en 2015

Contralateral non-operated nerve to transected rat sciatic nerve shows increased expression of IL-1beta, TGF-beta1, TNF-alpha, and IL-10

artículo científico publicado en 2002

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

artículo científico publicado en 2015

Curative effects of recombinant human Interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis

artículo científico publicado en 2001

Cytokine responses during chronic denervation

artículo científico publicado en 2005

Decreased Expression of VEGF-A in Rat Experimental Autoimmune Encephalomyelitis and in Cerebrospinal Fluid Mononuclear Cells from Patients with Multiple Sclerosis

artículo científico publicado en 2006

Depletion of Vbeta5.2/5.3 T cells with a humanized antibody in patients with multiple sclerosis

scientific article published on 01 March 2002

Distinct expression of TGF-beta1 mRNA in the endo- and epineurium after nerve injury

scientific article published on 01 July 2004

Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins

artículo científico publicado en 2016

Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.

artículo científico publicado en 2006

Effects of natalizumab treatment on the cerebrospinal fluid proteome of multiple sclerosis patients

scientific article published on 04 February 2013

Expression of MHC class I and beta2-microglobulin in rat spinal motoneurons: regulatory influences by IFN-gamma and axotomy

scientific article published on 01 April 1998

Expression of MHC class I heavy chain and beta2-microglobulin in rat brainstem motoneurons and nigral dopaminergic neurons

scientific article published on 01 November 1999

FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis

artículo científico publicado en 2012

Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery?

artículo científico publicado en 2009

Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis.

artículo científico publicado en 2014

High levels of 15-oxygenated steroids in circulation of patients with multiple sclerosis: fact or fiction?

artículo científico publicado en 2010

IL-22 Binding Protein Promotes the Disease Process in Multiple Sclerosis

scientific article published on 10 July 2019

Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation

artículo científico publicado en 2012

Identification of novel candidate protein biomarkers for the post-polio syndrome - implications for diagnosis, neurodegeneration and neuroinflammation

artículo científico publicado en 2008

Immunological patterns identifying disease course and evolution in multiple sclerosis patients

Impact of genetic risk loci for multiple sclerosis on expression of proximal genes in patients

artículo científico publicado en 2018

In-situ detection of both inflammatory and anti-inflammatory cytokines in resting peripheral blood mononuclear cells during pregnancy

scientific article published on 01 February 2003

Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression

artículo científico publicado en 2008

Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients

artículo científico publicado en 2003

Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.

artículo científico publicado en 2009

Increased numbers of IL-7 receptor molecules on CD4+CD25-CD107a+ T-cells in patients with autoimmune diseases affecting the central nervous system

artículo científico publicado en 2009

Increased numbers of mononuclear cells from blood and CSF expressing interferon-gamma mRNA in multiple sclerosis are from both the CD4+ and the CD8+ subsets

artículo científico publicado en 2000

Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis

scientific article published on 01 October 1998

Increased β-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases.

artículo científico publicado en 2015

Induction of systemic TNFalpha in natalizumab-treated multiple sclerosis

artículo científico publicado en 2008

Inflammation-related plasma and CSF biomarkers for multiple sclerosis

scientific article published on 26 May 2020

Inflammatory and haemostatic markers in idiopathic intracranial hypertension

artículo científico publicado en 2011

Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.

artículo científico publicado en 2013

Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment.

artículo científico publicado en 2000

Interleukin 18 receptor 1 expression distinguishes patients with multiple sclerosis.

artículo científico publicado en 2010

Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up.

artículo científico publicado en 2012

JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variants

artículo científico publicado en 2014

Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination

artículo científico publicado en 2016

MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

scientific journal article

Maternal MHC regulates generation of pathogenic antibodies and fetal MHC-encoded genes determine susceptibility in congenital heart block

artículo científico publicado en 2010

Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis

artículo científico publicado en 1996

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

artículo científico publicado en 2017

Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.

artículo científico publicado en 2012

Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells

artículo científico publicado en 2014

Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers

article

Neurofascin as a target for autoantibodies in peripheral neuropathies

artículo científico publicado en 2012

No evidence of IL21 association with multiple sclerosis in a Swedish population

article

Non-MHC gene regulation of nerve root injury induced spinal cord inflammation and neuron death

article

Non-parametric combination analysis of multiple data types enables detection of novel regulatory mechanisms in T cells of multiple sclerosis patients

scientific article published on 19 August 2019

Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis

artículo científico publicado en 2010

Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice

artículo científico publicado en 2012

Peripheral nerve injury induces endoneurial expression of IFN-gamma, IL-10 and TNF-alpha mRNA

scientific article published on 01 January 2000

Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis.

artículo científico publicado en 2008

Plasma CD93 concentration is a potential novel biomarker for coronary artery disease

scholarly article by Anders Mälarstig et al published 21 March 2011 in Journal of Internal Medicine

Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod.

artículo científico publicado en 2017

Prior poliomyelitis-IVIg treatment reduces proinflammatory cytokine production

artículo científico publicado en 2004

Prior poliomyelitis-evidence of cytokine production in the central nervous system

artículo científico publicado en 2002

Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid

artículo científico publicado en 2015

RGMA and IL21R show association with experimental inflammation and multiple sclerosis

article

Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis

artículo científico publicado en 2000

Serum levels of LIGHT in MS

article by Clas Malmeström et al published 4 October 2012 in Multiple Sclerosis Journal

Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression

artículo científico publicado en 2013

TLR activation induces TNF-alpha production from adult neural stem/progenitor cells.

artículo científico publicado en 2009

The balance of expression of PTPN22 splice forms is significantly different in rheumatoid arthritis patients compared with controls

artículo científico publicado en 2012

The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers.

artículo científico publicado en 2009

The expression of VEGF-A is down regulated in peripheral blood mononuclear cells of patients with secondary progressive multiple sclerosis

artículo científico publicado en 2011

The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity

artículo científico publicado en 2014

Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis

Von Willebrand Factor Gene Variants Associate with Herpes simplex Encephalitis.

artículo científico publicado en 2016

γ-Secretase directly sheds the survival receptor BCMA from plasma cells

artículo científico publicado en 2015

Lista de obras de Mohsen Khademi

A Role for VAV1 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.

Absence of systemic oxidative stress and increased CSF prostaglandin F2α in progressive MS.

Affinity proteomic profiling of plasma, cerebrospinal fluid, and brain tissue within multiple sclerosis.

Age-dependent effects on the treatment response of natalizumab in MS patients

Altered expression of T cell immunoglobulin-mucin (TIM) molecules in bronchoalveolar lavage CD4+ T cells in sarcoidosis

Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): suppression of IFN-gamma and TNF-alpha and enhancement of IL-10

Analysis of JC virus DNA in NPSLE patients treated with different immunomodulatory agents

Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.

Anoctamin 2 identified as an autoimmune target in multiple sclerosis

Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis

Antibody Affinity Against 2009 A/H1N1 Influenza and Pandemrix Vaccine Nucleoproteins Differs Between Childhood Narcolepsy Patients and Controls

Antibody-based profiling of cerebrospinal fluid within multiple sclerosis

Antibody-mediated suppression of Vbeta5.2/5.3(+) T cells in multiple sclerosis: results from an MRI-monitored phase II clinical trial

Autoantibody profiling in multiple sclerosis using arrays of human protein fragments

Autoantibody targets in vaccine-associated narcolepsy

CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis

Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.

Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis

Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis.

Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms

Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes

Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function

Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis.

Contralateral non-operated nerve to transected rat sciatic nerve shows increased expression of IL-1beta, TGF-beta1, TNF-alpha, and IL-10

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

Curative effects of recombinant human Interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis

Cytokine responses during chronic denervation

Decreased Expression of VEGF-A in Rat Experimental Autoimmune Encephalomyelitis and in Cerebrospinal Fluid Mononuclear Cells from Patients with Multiple Sclerosis

Depletion of Vbeta5.2/5.3 T cells with a humanized antibody in patients with multiple sclerosis

Distinct expression of TGF-beta1 mRNA in the endo- and epineurium after nerve injury

Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins

Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.

Effects of natalizumab treatment on the cerebrospinal fluid proteome of multiple sclerosis patients

Expression of MHC class I and beta2-microglobulin in rat spinal motoneurons: regulatory influences by IFN-gamma and axotomy

Expression of MHC class I heavy chain and beta2-microglobulin in rat brainstem motoneurons and nigral dopaminergic neurons

FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis

Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery?

Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis.

High levels of 15-oxygenated steroids in circulation of patients with multiple sclerosis: fact or fiction?

IL-22 Binding Protein Promotes the Disease Process in Multiple Sclerosis

Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation

Identification of novel candidate protein biomarkers for the post-polio syndrome - implications for diagnosis, neurodegeneration and neuroinflammation

Immunological patterns identifying disease course and evolution in multiple sclerosis patients

Impact of genetic risk loci for multiple sclerosis on expression of proximal genes in patients

In-situ detection of both inflammatory and anti-inflammatory cytokines in resting peripheral blood mononuclear cells during pregnancy

Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression

Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients

Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.

Increased numbers of IL-7 receptor molecules on CD4+CD25-CD107a+ T-cells in patients with autoimmune diseases affecting the central nervous system

Increased numbers of mononuclear cells from blood and CSF expressing interferon-gamma mRNA in multiple sclerosis are from both the CD4+ and the CD8+ subsets

Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis

Increased β-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases.

Induction of systemic TNFalpha in natalizumab-treated multiple sclerosis

Inflammation-related plasma and CSF biomarkers for multiple sclerosis

Inflammatory and haemostatic markers in idiopathic intracranial hypertension

Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.

Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment.

Interleukin 18 receptor 1 expression distinguishes patients with multiple sclerosis.

Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up.

JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variants

Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination

MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

Maternal MHC regulates generation of pathogenic antibodies and fetal MHC-encoded genes determine susceptibility in congenital heart block

Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.

Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells

Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers

Neurofascin as a target for autoantibodies in peripheral neuropathies

No evidence of IL21 association with multiple sclerosis in a Swedish population

Non-MHC gene regulation of nerve root injury induced spinal cord inflammation and neuron death

Non-parametric combination analysis of multiple data types enables detection of novel regulatory mechanisms in T cells of multiple sclerosis patients

Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis

Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice

Peripheral nerve injury induces endoneurial expression of IFN-gamma, IL-10 and TNF-alpha mRNA